Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

(Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

President Donald Trump's executive order mandates drugmakers to lower prices to match those in affluent nations, threatening ...

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Current health news covers major investments by Merck Animal Health and Gilead Sciences in the U.S., regulatory decisions ...

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their ...

President Donald Trump will sign an executive order Monday to link the cost of drugs to prices abroad, under a so-called ...